Efficacy of Echocardiography for Differential Diagnosis of Left Ventricular Hypertrophy: Special Focus on Speckle-tracking Longitudinal Strain

Overview

Journal J Echocardiogr

Specialties Cardiology & Vascular Diseases
Radiology

Date 2021 Jan 18

PMID 33460030

Citations 18

Authors

Hidekazu Tanaka

Affiliations

Soon will be listed here.

Abstract

Left ventricular (LV) hypertrophy (LVH) is a frequent imaging finding in daily clinical practice, and its presence is associated with poor outcomes and ventricular arrhythmias. It is commonly detected in athletes, arterial hypertension, aortic stenosis, hypertrophic cardiomyopathy, cardiac amyloidosis, Fabry disease, or Friedreich's ataxia. Echocardiography plays an important role in detecting LVH and underlying causes in current clinical practice. While echocardiography is essential for the quantification and early detection of LV structural findings for various cardiovascular diseases, it has been reported that speckle-tracking echocardiographic parameters are also useful for the detection of early LV structural abnormalities. In particular, global longitudinal strain (GLS) assessed by two-dimensional speckle-tracking echocardiography is reportedly a sensitive marker for early subtle abnormalities of LV myocardial performance, helpful for the prediction of outcomes for various cardiac diseases, and superior to conventional echocardiographic indices. GLS is determined as the averaged peak longitudinal strain of 18 LV segments from standard apical views and can be assessed as a polar plot. This polar plot longitudinal strain mapping offers an intuitive visual overview of the global and regional LV longitudinal myocardial function status of various cardiomyopathies with LVH. This mapping is clinically practicable and the plot patterns obtainable as the result of further development of this technique for clinical practice provide clues to the etiology of cardiomyopathies. This article reviews the efficacy of echocardiography for differential diagnosis of LVH, with a special focus on the utility of speckle-tracking longitudinal strain.

Citing Articles

Advances and challenges in echocardiographic diagnosis and management of cardiac amyloidosis.

Tian Y, Liu H Int J Cardiovasc Imaging. 2025; .

PMID: 40009119 DOI: 10.1007/s10554-025-03362-5.

International Validation of Echocardiographic AI Amyloid Detection Algorithm.

Duffy G, Oikonomou E, Hourmozdi J, Usuku H, Patel J, Stern L medRxiv. 2025; .

PMID: 39763545 PMC: 11702730. DOI: 10.1101/2024.12.14.24319049.

Echocardiographic findings of patients with transthyretin amyloid cardiomyopathy.

Usuku H, Oike F, Kuyama N, Hirakawa K, Takashio S, Izumiya Y J Echocardiogr. 2024; 23(1):1-9.

PMID: 39729212 DOI: 10.1007/s12574-024-00672-w.

Apical Sparing of Longitudinal Strain as a Specific Pattern of Myocardial Fibrosis in Patients with Severe Left Ventricular Hypertrophy: A Comparison between Deformation Imaging and Histological Findings.

Yelenski S, Zayat R, Spillner J, Donuru S, Kolashov A, Khattab M J Clin Med. 2024; 13(20).

PMID: 39458092 PMC: 11508479. DOI: 10.3390/jcm13206141.

Progress in diagnosis and treatment of hypertension combined with left ventricular hypertrophy.

Han Y, Li Y, Wu Z, Pei Y, Lu S, Yu H Ann Med. 2024; 56(1):2405080.

PMID: 39301864 PMC: 11418038. DOI: 10.1080/07853890.2024.2405080.

References

Treibel T, Fontana M, Gilbertson J, Castelletti S, White S, Scully P . Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. Circ Cardiovasc Imaging. 2016; 9(8). DOI: 10.1161/CIRCIMAGING.116.005066. View

Soufi Taleb Bendiab N, Meziane-Tani A, Ouabdesselam S, Methia N, Latreche S, Henaoui L . Factors associated with global longitudinal strain decline in hypertensive patients with normal left ventricular ejection fraction. Eur J Prev Cardiol. 2017; 24(14):1463-1472. DOI: 10.1177/2047487317721644. View

Kansal M, Lester S, Surapaneni P, Sengupta P, Appleton C, Ommen S . Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy. Am J Cardiol. 2011; 108(9):1322-6. DOI: 10.1016/j.amjcard.2011.06.053. View

Phelan D, Collier P, Thavendiranathan P, Popovic Z, Hanna M, Plana J . Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012; 98(19):1442-8. DOI: 10.1136/heartjnl-2012-302353. View

DAndrea A, Cocchia R, Riegler L, Scarafile R, Salerno G, Gravino R . Left ventricular myocardial velocities and deformation indexes in top-level athletes. J Am Soc Echocardiogr. 2010; 23(12):1281-8. DOI: 10.1016/j.echo.2010.09.020. View

Tanaka H . Utility of strain imaging in conjunction with heart failure stage classification for heart failure patient management. J Echocardiogr. 2018; 17(1):17-24. DOI: 10.1007/s12574-018-0408-2. View

Liu D, Hu K, Niemann M, Herrmann S, cikes M, Stork S . Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013; 6(6):1066-72. DOI: 10.1161/CIRCIMAGING.113.000683. View

Biering-Sorensen T, Biering-Sorensen S, Olsen F, Sengelov M, Jorgensen P, Mogelvang R . Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study. Circ Cardiovasc Imaging. 2017; 10(3). PMC: 5363277. DOI: 10.1161/CIRCIMAGING.116.005521. View

Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T . JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circ J. 2020; 84(9):1610-1671. DOI: 10.1253/circj.CJ-20-0110. View

10.

Selvanayagam J, Hawkins P, Paul B, Myerson S, Neubauer S . Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol. 2007; 50(22):2101-10. DOI: 10.1016/j.jacc.2007.08.028. View

11.

Liu D, Hu K, Niemann M, Herrmann S, cikes M, Stork S . Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PLoS One. 2013; 8(3):e56923. PMC: 3592864. DOI: 10.1371/journal.pone.0056923. View

12.

Hachicha Z, Dumesnil J, Bogaty P, Pibarot P . Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007; 115(22):2856-64. DOI: 10.1161/CIRCULATIONAHA.106.668681. View

13.

Swanton R, Brooksby I, Davies M, Coltart D, Jenkins B, Webb-Peploe M . Systolic and diastolic ventricular function in cardiac amyloidosis. Studies in six cases diagnosed with endomyocardial biopsy. Am J Cardiol. 1977; 39(5):658-64. DOI: 10.1016/s0002-9149(77)80125-2. View

14.

Pelliccia A, Maron B, Spataro A, Proschan M, Spirito P . The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991; 324(5):295-301. DOI: 10.1056/NEJM199101313240504. View

15.

Kramer J, Niemann M, Liu D, Hu K, Machann W, Beer M . Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J. 2013; 34(21):1587-96. DOI: 10.1093/eurheartj/eht098. View

16.

Losi M, Nistri S, Galderisi M, Betocchi S, Cecchi F, Olivotto I . Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment. Cardiovasc Ultrasound. 2010; 8:7. PMC: 2848131. DOI: 10.1186/1476-7120-8-7. View

17.

cikes M, Sutherland G, Anderson L, Bijnens B . The role of echocardiographic deformation imaging in hypertrophic myopathies. Nat Rev Cardiol. 2010; 7(7):384-96. DOI: 10.1038/nrcardio.2010.56. View

18.

Regner S, Lagedrost S, Plappert T, Paulsen E, Friedman L, Snyder M . Analysis of echocardiograms in a large heterogeneous cohort of patients with friedreich ataxia. Am J Cardiol. 2011; 109(3):401-5. DOI: 10.1016/j.amjcard.2011.09.025. View

19.

Castano A, Narotsky D, Hamid N, Khalique O, Morgenstern R, DeLuca A . Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J. 2017; 38(38):2879-2887. PMC: 5837725. DOI: 10.1093/eurheartj/ehx350. View

20.

Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View